| Immune checkpoint inhibitors: recent progress and potential biomarkers P Darvin, SM Toor, V Sasidharan Nair, E Elkord Experimental & molecular medicine 50 (12), 1-11, 2018 | 1857 | 2018 |
| T‐cell responses and therapies against SARS‐CoV‐2 infection SM Toor, R Saleh, V Sasidharan Nair, RZ Taha, E Elkord Immunology 162 (1), 30-43, 2021 | 200 | 2021 |
| Immune checkpoints in the tumor microenvironment SM Toor, VS Nair, J Decock, E Elkord Seminars in cancer biology 65, 1-12, 2020 | 180 | 2020 |
| Immune Checkpoints in Circulating and Tumor-Infiltrating CD4+ T Cell Subsets in Colorectal Cancer Patients SM Toor, K Murshed, M Al-Dhaheri, M Khawar, M Abu Nada, E Elkord Frontiers in immunology 10, 2936, 2019 | 124 | 2019 |
| Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment ASS Khaja, SM Toor, H El Salhat, I Faour, NU Haq, BR Ali, E Elkord Oncotarget 8 (20), 33159, 2017 | 116 | 2017 |
| Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells V Sasidharan Nair, SM Toor, BR Ali, E Elkord Expert opinion on therapeutic targets 22 (6), 547-557, 2018 | 103 | 2018 |
| Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer R Saleh, RZ Taha, SM Toor, V Sasidharan Nair, K Murshed, M Khawar, ... Cancer Immunology, Immunotherapy 69, 1989-1999, 2020 | 91 | 2020 |
| Intratumoral FoxP3+ Helios+ regulatory T cells upregulating immunosuppressive molecules are expanded in human colorectal cancer AS Syed Khaja, SM Toor, H El Salhat, BR Ali, E Elkord Frontiers in Immunology 8, 263524, 2017 | 88 | 2017 |
| Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells R Saleh, SM Toor, S Khalaf, E Elkord Vaccines 7 (4), 149, 2019 | 86 | 2019 |
| DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer V Sasidharan Nair, SM Toor, RZ Taha, H Shaath, E Elkord Clinical epigenetics 10, 1-9, 2018 | 85 | 2018 |
| Myeloid cells in circulation and tumor microenvironment of breast cancer patients SM Toor, AS Syed Khaja, H El Salhat, I Faour, J Kanbar, AA Quadri, ... Cancer Immunology, Immunotherapy 66, 753-764, 2017 | 83 | 2017 |
| Role of epigenetic modifications in inhibitory immune checkpoints in cancer development and progression R Saleh, SM Toor, V Sasidharan Nair, E Elkord Frontiers in immunology 11, 544793, 2020 | 67 | 2020 |
| Increased levels of circulating and tumor-infiltrating granulocytic myeloid cells in colorectal cancer patients SM Toor, AS Syed Khaja, H El Salhat, O Bekdache, J Kanbar, M Jaloudi, ... Frontiers in Immunology 7, 560, 2016 | 65 | 2016 |
| In-vitro effect of pembrolizumab on different T regulatory cell subsets SM Toor, AS Syed Khaja, I Alkurd, E Elkord Clinical & Experimental Immunology 191 (2), 189-197, 2018 | 54 | 2018 |
| Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer V Sasidharan Nair, R Saleh, SM Toor, RZ Taha, AA Ahmed, MA Kurer, ... Clinical epigenetics 12, 1-15, 2020 | 52 | 2020 |
| Therapeutic prospects of targeting myeloid‐derived suppressor cells and immune checkpoints in cancer SM Toor, E Elkord Immunology and cell biology 96 (9), 888-897, 2018 | 48 | 2018 |
| Transcriptomic analyses revealed systemic alterations in gene expression in circulation and tumor microenvironment of colorectal cancer patients H Shaath, S Toor, VS Nair, E Elkord, NM Alajez Cancers 11 (12), 1994, 2019 | 33 | 2019 |
| Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment V Sasidharan Nair, R Saleh, SM Toor, FS Cyprian, E Elkord Cancer immunology, immunotherapy 70, 2103-2121, 2021 | 27 | 2021 |
| An evaluation of sorter induced cell stress (SICS) on peripheral blood mononuclear cells (PBMCs) after different sort conditions-Are your sorted cells getting SICS? G Pfister, SM Toor, VS Nair, E Elkord Journal of immunological methods 487, 112902, 2020 | 25 | 2020 |
| Differential gene expression of tumor-infiltrating CD8+ T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis R Saleh, VS Nair, SM Toor, RZ Taha, K Murshed, M Al-Dhaheri, ... Journal for ImmunoTherapy of Cancer 8 (2), 2020 | 25 | 2020 |
Eyad ElkordProfessor of Immunology, XJTLU, Suzhou & Honorary Professor, University of Salford, ManchesterΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα salford.ac.uk
